Photo of Paula Coulter

Paula Coulter

Mrs

  • Room 02.030 - CCRCB Block 5 MBC Site

    United Kingdom

20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paula Coulter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Triple Negative Breast Neoplasms Medicine & Life Sciences
Prostaglandin H2 Receptors Thromboxane A2 Medicine & Life Sciences
Molecular Evolution Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

Defining the molecular evolution of extrauterine high grade serous carcinoma

Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.

Research output: Contribution to journalArticle

Molecular Evolution
Carcinoma
Fallopian Tubes
Carcinoma in Situ
Epithelium
1 Citation (Scopus)

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

Mullan, P. B., Bingham, V., Haddock, P., Irwin, G. W., Kay, E., McQuaid, S. & Buckley, N. E., 02 Apr 2019, In : BMC Cancer. 19, 13 p., 236.

Research output: Contribution to journalArticle

Open Access
File
Triple Negative Breast Neoplasms
Anthracyclines
Drug Therapy
Standard of Care
Biomarkers
14 Citations (Scopus)

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer

Buckley, N. E., Haddock, P., De Matos Simoes, R., Parkes, E., Irwin, G., Emmert-Streib, F., McQuaid, S., Kennedy, R. & Mullan, P., 02 Mar 2016, In : Oncotarget. 13 p.

Research output: Contribution to journalArticle

Open Access
File
Triple Negative Breast Neoplasms
Neoplasms
Breast Neoplasms
Therapeutics
Tumor Microenvironment
4 Citations (Scopus)

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)

Orr, K., Buckley, N. E., Haddock, P., James, C., Parent, J-L., McQuaid, S. & Mullan, P., 30 Jul 2016, In : Oncotarget. 15 p.

Research output: Contribution to journalArticle

Open Access
File
Prostaglandin H2 Receptors Thromboxane A2
Triple Negative Breast Neoplasms
Breast Neoplasms
Recurrence
rho-Associated Kinases